PLAT and Stroke: Pathophysiological responses after stroke are complex, and presently, no better choice is available for stroke treatment except tissue plasminogen activator (Otero-Ortega et al., 2019; Pan et al., 2020), the only useful drug within 4–6 h of clearly defined symptom onset (Malone et al., 2019; Wang J. et al., 2020).